Business people may favor better governmental coordination of the regulatory hoops they must jump through, but like other Faustian bargains, this entails risk. If the history of U.S. medical device regulation is any indication, the current push for international regulatory harmonization will result in raising regulatory hurdles at least as high the highest levels previously reached.
|Other Independent Review articles by Robert Higgs|
|Winter 2017||First, Do No Harm|
|Fall 2016||Can the State Enforce Virtuous Behavior?|
|Summer 2016||Douglass C. North: Trailblazer|
|[View All (55)]|